Skip to main navigation Skip to main content Skip to page footer

Infezioni da zecche

Informazioni cliniche

Le zecche possono trasmettere all'uomo diversi agenti infettivi virali, batterici e parassitari durante il pasto di sangue. Oltre alla Borrelia, che causa la borreliosi di Lyme, la più frequente malattia trasmessa dalle zecche nell'emisfero settentrionale, la gamma di agenti patogeni comprende il virus della TBE, il virus della febbre di Crimea-Congo, l'Anaplasma, la Rickettsia, la Babesia, l'Ehrlichia e la Coxiella. A seconda dell'agente patogeno, le infezioni da zecche possono provocare vari sintomi clinici, conivolgendo ad esempio la pelle, le articolazioni, i muscoli, gli organi interni e il sistema nervoso centrale. Il decorso della malattia varia da asintomatico o subclinico a grave e pericoloso per la vita. Poiché esistono vaccini solo per alcuni dei patogeni trasmessi dalle zecche, la profilassi dell‘esposizione è la misura di protezione più efficace.

Diagnostica

Laboratory diagnostics of tick-borne infections are based on direct and indirect detection methods. Direct procedures include e.g. blood smears, pathogen cultures or PCR-based tests, while indirect detection is mainly based on the detection of specific antibodies against the respective pathogen in patient serum, plasma or CSF. Detection of antibodies is the most important laboratory diagnostic method in cases where it is difficult to obtain suitable sample materials for direct detection, or the amount of pathogen in the sample is too low. For antibody determination in cases of suspected tick-borne infection, EUROIMMUN offers a wide range of serological test systems, including ELISAs, ChLIAs, immunofluorescence tests (IIFT), immunoblots and EUROMicroblots, miniaturised immunoblots in microplate format.

La diagnostica di laboratorio delle infezioni da zecche si basa su metodi di rilevamento diretti e indiretti. Le procedure dirette comprendono, ad esempio, esami su strisci di sangue, colture di patogeni o test basati sulla PCR, mentre il rilevamento indiretto si basa principalmente sulla rilevazione di anticorpi specifici contro il rispettivo patogeno nel siero, nel plasma o nel liquor del paziente. La determinazione degli anticorpi è il metodo diagnostico di laboratorio più importante nei casi in cui è difficile ottenere materiali di campionamento adatti per la rilevazione diretta o la quantità di patogeno nel campione è troppo bassa. Per la determinazione degli anticorpi nei casi di sospetta infezione da zecche, EUROIMMUN offre un'ampia gamma di sistemi di test sierologici, tra cui ELISA, ChLIA, test di immunofluorescenza (IIFT), immunoblots ed EUROMicroblots, immunoblots miniaturizzati in formato micropiastra.

Methods
Technology Parameter Substrate Species Calibration Ig Class Format Order No.
ELISA Anti-TBE Virus CSF ELISA 2.0 (IgG)
tick-borne encephalitis virus
antigen-coated
microplate wells
TBE viral proteins 5/25/50/100/175/230 U/ml IgG 96 x 01
EI 2661-9601-2L G
ELISA Anti-TBE Virus CSF ELISA 2.0 (IgM)
tick-borne encephalitis virus
antigen-coated
microplate wells
TBE viral proteins IgM 96 x 01
EI 2661-9601-2L M
ELISA CSQ pair of controls
anti-Borrelia (IgG)
IgG 02 x 20
CK 2132-0220-L G
ELISA Anti-Borrelia CSF ELISA 2.0 (IgM) antigen-coated
microplate wells
TBE viral proteins IgM 96 x 01
EI 2132-9601-2L M
ELISA CSF: Anti-Borrelia plus VlsE ELISA (IgG)
Sample type: CSF/serum pair
antigen-coated
microplate wells
whole antigen, detergent extracts of
Borrelia burgdorferi sensu stricto,
Borrelia garinii and Borrelia afzelii
PLUS recombinant VlsE from
Borrelia burgdorferi sensu stricto
5/25/50/100/175/230 U IgG 96 x 01
EI 2132-9601-L G
EUROLINE Anti-Borrelia EUROLINE-RN-AT (IgG)
(p18, p19, p20, p21, p58,
OspC (p25), p39, p83, LBb, LBa,
VlsE Bg, VlsE Bb, VlsE Ba separately)
EUROLINE IgG
IgG
IgG
240 x 01
32 x 01
50 x 01
DN 2131-24001 G
DN 2131-3201 G
DN 2131-5001 G
EUROLINE Anti-Borrelia EUROLINE-RN-AT (IgM)
(OspC Bg native, OspC Bb native,
OspC Ba native, p39, VlsE Bb separately)
EUROLINE IgM
IgM
IgM
240 x 01
32 x 01
50 x 01
DN 2131-24001 M
DN 2131-3201 M
DN 2131-5001 M
ELISA Anti-Crimean-Congo fever virus(CCHFV) ELISA (IgG) antigen-coated
microplate wells
recombinant
protein from CCHFV
2/20/200 RU/ml IgG 96 x 01
EI 279a-9601 G
ELISA Anti-Crimean-Congo fever virus(CCHFV) ELISA (IgM) antigen-coated
microplate wells
recombinant
protein from CCHFV
semi-quantitative IgM 96 x 01
EI 279a-9601 M
IIFT TBE virus (TBEV) infected and non-
infected cells
(2 BIOCHIPs per field)
EU 14 IgG
IgM
IgG
IgM
10 x 05
10 x 05
10 x 10
10 x 10
FI 2661-1005 G
FI 2661-1005 M
FI 2661-1010 G
FI 2661-1010 M
IIFT Flavivirus Mosaic 1
TBE virus (TBEV)
West Nile virus (WNV)
Japanese encephalitis virus (JEV)
Yellow fever virus (YFV)
4 BIOCHIPs per field:
infected cells
infected cells
infected cells
infected cells

EU 14
EU 14
EU 14
EU 14
IgG
IgM
IgG
IgM
10 x 05
10 x 05
10 x 10
10 x 10
FI 2661-1005-1 G
FI 2661-1005-1 M
FI 2661-1010-1 G
FI 2661-1010-1 M
IIFT Flavivirus Profile 2
upper row:
TBE virus (TBEV)
West Nile virus (WNV)
Japanese encephalitis virus (JEV)
Yellow fever virus (YFV)
bottom row:
Dengue virus
types 1 - 4 (DENV)


infected cells
infected cells
infected cells
infected cells

infected cells


EU 14
EU 14
EU 14
EU 14

EU 14
IgG
IgM
IgG
IgM
10 x 05
10 x 05
20 x 05
20 x 05
FI 2661-1005-2 G
FI 2661-1005-2 M
FI 2661-2005-2 G
FI 2661-2005-2 M
ELISA Anti-TBE Virus ELISA 2.0 (IgG)
tick-borne encephalitis virus
antigen-coated
microplate wells
TBE viral proteins IgG 96 x 01
EI 2661-9601-2 G
ELISA Anti-TBE Virus ELISA 2.0 (IgM)
tick-borne encephalitis virus
antigen-coated
microplate wells
semi-quantitative IgM 96 x 01
EI 2661-9601-2 M
IIFT EUROPLUS
Borrelia afzelii
Borrelia burgdorferi (USA)
OspC antigen
VlsE antigen
4 BIOCHIPs per field:
bacterial smear
bacterial smear
OspC BIOCHIPs
VlsE BIOCHIPs

B. afzelii
B. burgd. (USA)
B. burgdorferi
recombinant
IgG
IgM
IgG
IgM
10 x 05
10 x 05
10 x 10
10 x 10
FI 2136-1005-1 G
FI 2136-1005-1 M
FI 2136-1010-1 G
FI 2136-1010-1 M
ELISA Anti-Borrelia ELISA (IgM)
whole antigen extracts of
Borrelia burgdorferi sensu stricto,
Borrelia garinii and Borrelia afzelii
antigen-coated
microplate wells
whole antigen, detergent extracts of
Borrelia burgdorferi sensu stricto,
Borrelia garinii and Borrelia afzelii
2/20/200 RU/ml IgM 96 x 01
EI 2132-9601 M
ELISA Anti-Borrelia plus VlsE ELISA (IgG)
whole antigen extracts of
Borrelia burgdorferi sensu stricto,
Borrelia garinii and Borrelia afzelii
plus recombinant VlsE
antigen-coated
microplate wells
whole antigen, detergent extracts of
Borrelia burgdorferi sensu stricto,
Borrelia garinii and Borrelia afzelii
plus recombinant VlsE from
Borrelia burgdorferi sensu stricto
2/20/200 RU/ml IgG 96 x 01
EI 2132-9601-2 G
ELISA Anti-Coxiella burnetii Phase 1 ELISA (IgG) antigen-coated
microplate wells
native antigens
from Coxiella burnetii cells
in the chronical phase
semi-quantitative IgG 96 x 01
EI 217a-9601-1 G
ELISA Anti-Coxiella burnetii Phase 2 ELISA (IgG) antigen-coated
microplate wells
native antigens
from Coxiella burnetii cells
in the acute phase
semi-quantitative IgG 96 x 01
EI 217a-9601-2 G
ELISA Anti-Coxiella burnetii Phase 2 ELISA (IgM) antigen-coated
microplate wells
native antigens
from Coxiella burnetii cells
in the acute phase
semi-quantitative IgM 96 x 01
EI 217a-9601-2 M
EUROLINE positive control serum: IgG, human, 50x concentrated
for Borrelia
IgG 05 x 07
CL 2131-0507 G
EUROLINE positive control serum: IgM, human, 50x concentrated
for Borrelia
IgM 05 x 07
CL 2131-0507 M
EUROLINE Anti-Borrelia EUROLINE-RN-AT-adv (IgM)
(OspC-adv Bsp, OspC-adv Bg, OspC-adv
Bb, OspC-adv Ba, p39, VlsE Bb separately)
EUROLINE IgM
IgM
IgM
240 x 01
32 x 01
50 x 01
DN 2131-24001-2 M
DN 2131-3201-2 M
DN 2131-5001-2 M
WESTERNBLOT antibodies against Borrelia afzelii
IgG positive control
(Westernblot/EUROLINE-WB)
IgG 50 x 05
CW 2131-5005 G
WESTERNBLOT antibodies against Borrelia afzelii
IgM positive control
(Westernblot/EUROLINE-WB)
IgM 50 x 05
CW 2131-5005 M
WESTERNBLOT antibodies against Borrelia burgdorferi
IgG positive control
IgG 50 x 05
CW 2132-5005 G
WESTERNBLOT antibodies against Borrelia burgdorferi
IgM positive control
IgM 50 x 05
CW 2132-5005 M
WESTERNBLOT antibodies against Borrelia garinii
IgG positive control
IgG 50 x 05
CW 2134-5005 G
WESTERNBLOT antibodies against Borrelia garinii
IgM positive control
IgM 50 x 05
CW 2134-5005 M
WESTERNBLOT Anti-Borrelia EUROLINE-WB (IgG) Westernblot whole antigen, SDS extract of
Borrelia afzelii plus VlsE
IgG
IgG
IgG
IgG
16 x 01
240 x 01
30 x 01
48 x 01
DY 2131-1601-1 G
DY 2131-24001-1 G
DY 2131-3001-1 G
DY 2131-4801-1 G
WESTERNBLOT Anti-Borrelia EUROLINE-WB (IgM) Westernblot whole antigen, SDS extract of
Borrelia afzelii plus VlsE
IgM
IgM
IgM
IgM
16 x 01
240 x 01
30 x 01
48 x 01
DY 2131-1601-1 M
DY 2131-24001-1 M
DY 2131-3001-1 M
DY 2131-4801-1 M
WESTERNBLOT Anti-Borrelia afzelii-WESTERNBLOT (IgG) Westernblot whole antigen, SDS extract of
Borrelia afzelii
IgG
IgG
240 x 01
30 x 01
DY 2131-24001 G
DY 2131-3001 G
WESTERNBLOT Anti-Borrelia afzelii-WESTERNBLOT (IgM) Westernblot whole antigen, SDS extract of
Borrelia afzelii
IgM
IgM
240 x 01
30 x 01
DY 2131-24001 M
DY 2131-3001 M
WESTERNBLOT Anti-Borrelia burgdorferi-WESTERNBLOT (IgG) Westernblot whole antigen, SDS extract of
Borrelia burgdorferi sensu stricto
IgG 30 x 01
DY 2132-3001 G
WESTERNBLOT Anti-Borrelia burgdorferi-WESTERNBLOT (IgM) Westernblot whole antigen, SDS extract of
Borrelia burgdorferi sensu stricto
IgM 30 x 01
DY 2132-3001 M
WESTERNBLOT Anti-Borrelia garinii-WESTERNBLOT (IgG) Westernblot whole antigen, SDS extract
of Borrelia garinii
IgG 30 x 01
DY 2134-3001 G
WESTERNBLOT Anti-Borrelia garinii-WESTERNBLOT (IgM) Westernblot whole antigen, SDS extract of
Borrelia garinii
IgM 30 x 01
DY 2134-3001 M
ChLIA IDS Borrelia IgG antigenic coated magnetic particles Borrelia burgdorferi VlsE antigen semi-quantitative
100 x 01
IS-ID62011
ChLIA IDS Borrelia IgM antigenic coated magnetic particles B. afzelii, B. burgdorferi, B. garinii, B. spielmani OspC and B. burgdorferi VlsE antigen semi-quantitative
100 x 01
IS-ID62021
ChLIA IDS Borrelia Control Set 3 x 1.5 ml Control 1/2 human serum 2 concentrations
IS-ID62301
ChLIA Anti-Borrelia ChLIA (IgG) Antigen-coated magnetic particles recombinant VlsE,
recombinant DbpA
quantitative IgG 100 x 1
LI 2132-10010 G
ChLIA Anti-Borrelia ChLIA (IgM) Antigen-coated magnetic particles recombinant OspC quantitative IgM 100 x 1
LI 2132-10010 M
ChLIA Control set Anti-Borrelia ChLIA (IgG) 2 x 0.5 ml control 1/2 IgG 02 x 02
LR 2132-20210 G
ChLIA Control set Anti-Borrelia ChLIA (IgM) 2 x 0.5 ml control 1/2 IgM 02 x 02
LR 2132-20210 M
MICROBLOT EUROMicroblot Anti Borrelia (IgG) IgG 96 x 01
KN 2131-9601 G
MICROBLOT EUROMicroblot Anti Borrelia (IgM) IgM 96 x 01
KN 2131-9601 M
* For research use only, not for in vitro diagnostic use in the sense of EU directive 98/79/EC.
1 Product manufactured by third party. Please contact your local Euroimmun representative for more information.